CTIS.eu › Cities › Greece › Larissa
Larissa
Greece
212 total trials
89 recruiting
2024-513018-36-00
5
2025-03-06
Lung Diseases, Interstitial
2024-512926-27-00
5
2024-12-12
patients with estrogen receptor-positive/human epidermal growth factor
2023-507746-83-00
5
2024-11-27
Generalized Myasthenia Gravis
2024-512707-40-00
4
2024-11-07
RELAPSING MULTIPLE SCLEROSIS
2022-502825-17-00
4
2024-10-07
Melanoma
2023-504231-41-01
10
2024-10-02
Locally advanced or metastatic urothelial cancer
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
2023-503699-25-00
5
2024-07-15
Progressive Pulmonary Fibrosis
2023-503697-21-01
5
2024-06-24
Idiopathic pulmonary fibrosis
2023-503904-10-00
5
2024-06-07
Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
2023-508153-12-00
5
2024-03-26
Hospital-acquired pneumonia
2022-501890-38-00
4
2024-02-16
acute ischemic stroke
2023-508123-12-00
10
2023-11-03
Post-Acute COVID Syndrome (PACS)
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
2022-500257-16-00
5
2023-03-17
Diabetic Foot Infections
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
2025-522705-37-00
4
2026-04-21
HIDRADENITIS SUPPURATIVA
2025-521036-11-00
5
2026-03-23
Immune system disseases
2025-521035-37-00
5
2026-03-02
Immune system diseases
Showing 25–48 of 212 trials